César Garcı́a-Rey

2.0k total citations
41 papers, 1.6k citations indexed

About

César Garcı́a-Rey is a scholar working on Epidemiology, Pharmacology and Microbiology. According to data from OpenAlex, César Garcı́a-Rey has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 12 papers in Pharmacology and 11 papers in Microbiology. Recurrent topics in César Garcı́a-Rey's work include Pneumonia and Respiratory Infections (22 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Bacterial Infections and Vaccines (11 papers). César Garcı́a-Rey is often cited by papers focused on Pneumonia and Respiratory Infections (22 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Bacterial Infections and Vaccines (11 papers). César Garcı́a-Rey collaborates with scholars based in Spain, India and France. César Garcı́a-Rey's co-authors include Fernando Baquero, L. Aguilar, Rafael Dal−Ré, Juan García-de-Lomas, Lorenzo Aguilar, Emilio Pérez‐Trallero, J. Casal, Emilio Bouza, Carlos Fernández-Mazarrasa and Rafael Cantón and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.

In The Last Decade

César Garcı́a-Rey

41 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
César Garcı́a-Rey Spain	21	1.2k	385	323	299	293	41	1.6k
Francisco Gudiol Spain	13	683 0.6×	236 0.6×	321 1.0×	240 0.8×	165 0.6×	23	1.2k
Núria Sabé Spain	30	2.1k 1.8×	284 0.7×	420 1.3×	512 1.7×	197 0.7×	64	2.9k
R. Verdaguer Spain	31	1.8k 1.6×	136 0.4×	292 0.9×	523 1.7×	260 0.9×	56	2.8k
Stephanie H. Factor United States	21	864 0.8×	295 0.8×	712 2.2×	456 1.5×	56 0.2×	47	2.2k
Inmaculada Grau Spain	23	906 0.8×	151 0.4×	323 1.0×	377 1.3×	243 0.8×	50	1.5k
Laura Calatayud Spain	26	1.1k 0.9×	129 0.3×	380 1.2×	290 1.0×	426 1.5×	58	1.7k
Paul B. Iannini United States	22	625 0.5×	333 0.9×	288 0.9×	424 1.4×	96 0.3×	43	1.6k
D. Fontanals Spain	22	1.1k 0.9×	103 0.3×	248 0.8×	272 0.9×	409 1.4×	57	1.5k
Hüsnü Pullukçu Türkiye	19	760 0.7×	131 0.3×	315 1.0×	339 1.1×	93 0.3×	142	1.2k
Lorenzo Aguilar Spain	25	1.2k 1.0×	487 1.3×	341 1.1×	497 1.7×	345 1.2×	81	1.9k

Countries citing papers authored by César Garcı́a-Rey

Since Specialization

Citations

This map shows the geographic impact of César Garcı́a-Rey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by César Garcı́a-Rey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites César Garcı́a-Rey more than expected).

Fields of papers citing papers by César Garcı́a-Rey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by César Garcı́a-Rey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by César Garcı́a-Rey. The network helps show where César Garcı́a-Rey may publish in the future.

Co-authorship network of co-authors of César Garcı́a-Rey

This figure shows the co-authorship network connecting the top 25 collaborators of César Garcı́a-Rey. A scholar is included among the top collaborators of César Garcı́a-Rey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with César Garcı́a-Rey. César Garcı́a-Rey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Escartín, Antonio, Francisco Coret, Bonaventura Casanova, et al.. (2013). Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers. BMC Neurology. 13(1). 82–82. 3 indexed citations

Sevillano, David, L. Aguilar, Luís Alou, et al.. (2010). Exposure–response analysis of tigecycline in pharmacodynamic simulations using different size inocula of target bacteria. International Journal of Antimicrobial Agents. 36(2). 137–144. 11 indexed citations

Alou, Luís, María-José Giménez, Fabio Cafini, et al.. (2009). In vitro effect of physiological concentrations of human albumin on the antibacterial activity of tigecycline. Journal of Antimicrobial Chemotherapy. 64(6). 1230–1233. 9 indexed citations

Rodríguez, Fernando, Brian Johnson, Fé Tubau, et al.. (2009). Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.. Journal of Antimicrobial Chemotherapy. 64(1). 69–72. 34 indexed citations

Giménez, María-José, César Garcı́a-Rey, José Barberán, & L. Aguilar. (2009). [Clinical experience with tigecycline in the treatment of nosocomial infections caused by isolates exhibiting prevalent resistance mechanisms].. PubMed. 22(1). 48–56. 4 indexed citations

Garau, Javier, Fernando Baquero, E Pérez-Trallero, et al.. (2008). Factors impacting on length of stay and mortality of community-acquired pneumonia. Clinical Microbiology and Infection. 14(4). 322–329. 91 indexed citations

Lacasa, J, et al.. (2007). Prophylaxis versus pre-emptive treatment for infective and inflammatory complications of surgical third molar removal: a randomized, double-blind, placebo-controlled, clinical trial with sustained release amoxicillin/clavulanic acid (1000/62.5mg). International Journal of Oral and Maxillofacial Surgery. 36(4). 321–327. 80 indexed citations

Carratalà, Jordi, et al.. (2006). Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones. Clinical Microbiology and Infection. 12. 2–11. 9 indexed citations

Calbo, Esther, et al.. (2006). Impact of amoxicillin, associated or not with clavulanic acid, on pharyngeal colonization and selection of Streptococcus pneumoniae resistance in children under 5 years of age. European Journal of Pediatrics. 166(5). 467–471. 6 indexed citations

10.

Garcı́a-Rey, César, et al.. (2006). Antibiotic consumption and generation of resistance in Streptococcus pneumoniae: the paradoxical impact of quinolones in a complex selective landscape. Clinical Microbiology and Infection. 12. 55–66. 20 indexed citations

11.

Albertí, Sebastián, César Garcı́a-Rey, M. Isabel García-Laorden, Rafael Dal‐Ré, & Juan García-de-Lomas. (2005). Survey of emm -Like Gene Sequences from Pharyngeal Isolates of Group C and Group G Streptococci Collected in Spain. Journal of Clinical Microbiology. 43(3). 1433–1436. 12 indexed citations

12.

Albertí, Sebastián, Guadalupe Cortés, César Garcı́a-Rey, et al.. (2004). Streptococcus pyogenes Pharyngeal Isolates with Reduced Susceptibility to Ciprofloxacin in Spain: Mechanisms of Resistance and Clonal Diversity. Antimicrobial Agents and Chemotherapy. 49(1). 418–420. 19 indexed citations

13.

Buti, Marı́a, Antoni Mas, M. Prieto, et al.. (2003). A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation. Journal of Hepatology. 38(6). 811–817. 128 indexed citations

14.

Garcı́a-Rey, César. (2003). Evolution of penicillin and erythromycin co-resistance in Streptococcus pneumoniae in Spain. International Journal of Antimicrobial Agents. 22(5). 541–544. 15 indexed citations

15.

Santos, José Ignacio, et al.. (2003). Clinical Characteristics and Response to Newer Quinolones inLegionellaPneumonia: A Report of 28 Cases. Journal of Chemotherapy. 15(5). 461–465. 6 indexed citations

16.

Albertí, Sebastián, César Garcı́a-Rey, M.Á. Domínguez, et al.. (2003). Survey of emm Gene Sequences from Pharyngeal Streptococcus pyogenes Isolates Collected in Spain and Their Relationship with Erythromycin Susceptibility. Journal of Clinical Microbiology. 41(6). 2385–2390. 49 indexed citations

17.

Baquero, Fernando, et al.. (2002). Antibiotic consumption and resistance selection in Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy. 50(suppl_3). 27–38. 86 indexed citations

18.

Garcı́a-Rey, César, et al.. (2002). Pharmacoepidemiological Analysis of Provincial Differences between Consumption of Macrolides and Rates of Erythromycin Resistance among Streptococcus pyogenes Isolates in Spain. Journal of Clinical Microbiology. 40(8). 2959–2963. 52 indexed citations

19.

Alou, Luís, Mário Ramirez, César Garcı́a-Rey, J. Prieto, & Hermı́nia de Lencastre. (2001). Streptococcus pneumoniae Isolates with Reduced Susceptibility to Ciprofloxacin in Spain: Clonal Diversity and Appearance of Ciprofloxacin-Resistant Epidemic Clones. Antimicrobial Agents and Chemotherapy. 45(10). 2955–2957. 29 indexed citations

20.

Garcı́a-Rey, César, et al.. (2000). Influences of Different Factors on Prevalence of Ciprofloxacin Resistance in Streptococcus pneumoniae in Spain . Antimicrobial Agents and Chemotherapy. 44(12). 3481–3482. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact